
When reporting good news in cancer research, there’s usually a caveat that the promising breakthrough needs another five to ten years of trials to progress to a clinical setting.
Not this time.

When reporting good news in cancer research, there’s usually a caveat that the promising breakthrough needs another five to ten years of trials to progress to a clinical setting.
Not this time.